Peptides as drugs: from screening to application.
Explore this paper's citation graph
Summary
The broad potential of peptides as drugs is summarized, with special emphasis on peptides which inhibit protein-protein interactions.
- Type
- review
- Published
- 2013-05-31
- Cited by
- 38
- References
- 93
- OpenAlex
- https://openalex.org/W2084207777
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22319577
Keywords
Peptide, Small molecule, Aptamer, Peptidomimetic, Chemistry
References
- A recombinant human scFv anti-Rh(D) antibody with multiple valences using a C-terminal fragment of C4-binding protein.
- The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications.
- Phage peptide display.
- The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.
- Peptide Arrays on Membrane Supports
- Structural basis of macromolecular recognition.
- A helper phage to improve single-chain antibody presentation in phage display
- Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation
- Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
- Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences
- Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide
- Functional Characterization of Recombinant Chloroplast Signal Recognition Particle*
- The ras recruitment system, a novel approach to the study of protein-protein interactions.
- A novel genetic system to detect proteinprotein interactions
- Split ubiquitin as a sensor of protein interactions in vivo.
- Shape-programmable macromolecules.
- Yeast surface display for screening combinatorial polypeptide libraries
- Tat-mediated delivery of heterologous proteins into cells.
- Anticalins®: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies
- Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion
Cited by
- Peptide Suboptimal Conformation Sampling for the Prediction of Protein-Peptide Interactions.
- Cell-penetrating peptides: strategies for anticancer treatment.
- Drugs from slugs. Part II--conopeptide bioengineering.
- Antidotes, antibody-mediated immunity and the future of pharmaceutical product development
- Characterisation of mouse monoclonal antibodies against rhesus macaque killer immunoglobulin-like receptors KIR3D
- Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy
- Real-Time Monitoring of Relative Peptide–Protein Interaction Strengths in the Yeast Two-Hybrid System
- Benchmarking B-Cell Epitope Prediction with Quantitative Dose-Response Data on Antipeptide Antibodies: Towards Novel Pharmaceutical Product Development
- Exploring Internal Ribosome Entry Sites as Therapeutic Targets
- NEW FRONTIERS IN DRUGGABILITY
- Inhibitors of HIV-1 entry.
- Inhibition of the ferric uptake regulator by peptides derived from anti-FUR peptide aptamers: coupled theoretical and experimental approaches.
- Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller
- An Amphiphilic Peptide Induces Apoptosis Through the miR29b-p53 Pathway in Cancer Cells
- Sequence-Dependent Interfacial Adsorption and Permeation of Dipeptides across Phospholipid Membranes.
- Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
- Development and Application of Yeast and Phage Display of Diverse Lanthipeptides
- Peptides as Therapeutic Agents for Inflammatory-Related Diseases
- Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration.
- EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers
Related papers
- Aptamer-enabled uptake of small molecule ligands
- Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications
- Can machine learning ‘transform’ peptides/peptidomimetics into small molecules? A case study with ghrelin receptor ligands
- Structure-Based DNA-Targeting Strategies with Small Molecule Ligands for Drug Discovery
- Protein–protein interactions as targets for small-molecule therapeutics in cancer
- In search of small molecules blocking interactions between HIV proteins and intracellular cofactors.
- Modulation of a conformational ensemble by a small molecule that inhibits key protein–protein interactions involved in cell adhesion
- Wrapping mimicking in drug‐like small molecules disruptive of protein–protein interfaces
- Molecular Imaging of Drug-Modulated Protein-Protein Interactions in Living Subjects